Target intelligence / Profile preview

Cytotoxic cytostatic activity via chemotherapy agents

Molecular classification
Other
01

Overview

Cytotoxic cytostatic activity via chemotherapy agents refers to the ability of antineoplastic drugs to kill cancer cells (cytotoxic) or halt their proliferation (cytostatic) through a variety of molecular mechanisms, including induction of DNA damage, inhibition of nucleic acid synthesis, disruption of microtubules, and activation of cell death pathways. This is a general therapeutic property encompassing a wide array of drug classes, each acting on different molecular targets within tumor cells.

02

Mechanism of action

Induction of DNA damage, inhibition of DNA or RNA synthesis, inhibition of topoisomerases, disruption of microtubule dynamics, generation of reactive oxygen species, and induction of apoptosis/cell cycle arrest.

03

Biological functions

Cell death (cytotoxicity)Inhibition of cell proliferation (cytostasis)ApoptosisCell cycle arrest
04

Disease associations

Cancer
05

Safety considerations

Myelosuppression (neutropenia, anemia, thrombocytopenia)Gastrointestinal toxicity (nausea, vomiting, mucositis)Alopecia (hair loss)NeurotoxicitySecondary malignanciesOrgan damage (cardiac, hepatic, renal, pulmonary), depending on the drug class
06

Interacting drugs

Alkylating agents (cyclophosphamide)

11 more in the full profile.

07

Biomarkers

No universal single biomarker; selection and monitoring are often based on: Tumor proliferation indices (e.g., Ki-67)DNA repair capacity (e.g., BRCA1/2 status for platinum drugs and PARP inhibitors)Expression of specific drug targets or resistance genes

Beyond the preview

Go deeper on Cytotoxic cytostatic activity via chemotherapy agents.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytotoxic cytostatic activity via chemotherapy agents.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call